House Majority Leader Steve Scalise has a ‘very treatable’ blood cancer

House Majority Leader Steve Scalise has a ‘very treatable’ blood cancer


U.S. House Majority Leader Rep. Steve Scalise (R-La.) listens during a press conference following a House Republican Conference meeting at the U.S. Capitol Building in Washington, D.C., July 18, 2023.

Anna Moneymaker | Getty Images

House Majority Leader Steve Scalise said Tuesday that he has been diagnosed with multiple myeloma, which he called “a very treatable blood cancer.”

The Louisiana Republican underwent tests after “not feeling like myself this past week,” he said in a statement. “I have now begun treatment, which will continue for the next several months.”

Scalise, 57, said he intends to continue working as he receives treatment and will return to Washington, D.C., but did not say precisely when.

Congress is slated to return to the U.S. Capitol after Labor Day for a busy month.

This isn’t the first time Scalise has dealt with a major health scare.

In 2017, he was one of six people injured in a mass shooting in Alexandria, Virginia, during a team practice for the annual Congressional Baseball Game.

Scalise was shot in the hip and the bullet ruptured several organs. He underwent months of surgeries and blood transfusions on the way to recovery.



Source

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know
Health

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food and Drug Administration may add its strongest safety warning to Covid shots – marking another major shift in vaccine oversight.  It could also expand a […]

Read More
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Health

‘The next protein’: Fiber is shaping up to be the latest grocery obsession

Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, U.S., February 9, 2024. Brian Snyder | Reuters One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the […]

Read More
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More